Ország: Egyesült Államok
Nyelv: angol
Forrás: NLM (National Library of Medicine)
AZD-1222 (UNII: B5S3K2V0G8) (AZD-1222 - UNII:B5S3K2V0G8)
AstraZeneca Pharmaceuticals LP
INTRAMUSCULAR
unapproved drug other
ASTRAZENECA COVID-19 VACCINE- AZD1222 INJECTION, SUSPENSION ASTRAZENECA PHARMACEUTICALS LP ---------- ASTRAZENECA COVID-19 VACCINE PACKAGE/LABEL DISPLAY PANEL – VIAL LABEL AstraZeneca COVID-19 Vaccine NDC 0310-1222-10 FOR USE UNDER EMERGENCY USE AUTHORIZATION Suspension for Intramuscular Injection After first use, discard after: 6 hours at 20°-25°C (68°-77°F), or 48 hours at 2°-8°C (36°-46°F) For Exp Date: see www.azcovid-19.com Multi-dose vial (10 doses of 0.5 mL) PACKAGE/LABEL DISPLAY PANEL – VIAL CARTON NDC 0310-1222-15 ASTRAZENECA COVID-19 VACCINE FOR USE UNDER EMERGENCY USE AUTHORIZATION Suspension for Intramuscular Injection STORE AT 2°-8°C (36°-46°F) IN ORIGINAL CARTON TO PROTECT FROM LIGHT. Do not freeze or shake. NO PRESERVATIVE. DISCARD 6 HOURS AFTER FIRST USE WHEN HELD AT 20°-25°C (68°-77°F). DISCARD 48 HOURS AFTER FIRST USE WHEN HELD AT 2°-8°C (36°-46°F). 10 Multi-dose vials (each vial contains 10 doses of 0.5 mL) AstraZeneca AstraZeneca ASTRAZENECA COVID-19 VACCINE azd1222 injection, suspension PRODUCT INFORMATION PRODUCT T YPE VACCINE ITE M CODE (SOURCE ) NDC:0 310 -1222 ROUTE OF ADMINISTRATION INTRAMUSCULAR ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH AZD-12 2 2 (UNII: B5S3K2V0 G8 ) (AZD-1222 - UNII:B5S3K2V0 G8 ) AZD-1222 50 0 0 0 0 0 0 0 0 0 {VP} in 0 .5 mL INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH HISTIDINE (UNII: 4QD39 79 8 7E) HISTIDINE MO NO HYDRO CHLO RIDE (UNII: 1D5Q9 32XM6 ) AstraZeneca Pharmaceuticals LP MAGNESIUM CHLO RIDE (UNII: 0 2F3473H9 O) PO LYSO RBATE 8 0 (UNII: 6 OZP39 ZG8 H) ALCO HO L (UNII: 3K9 9 58 V9 0 M) SUCRO SE (UNII: C151H8 M554) SO DIUM CHLO RIDE (UNII: 451W47IQ8 X) EDETATE DISO DIUM (UNII: 7FLD9 1C8 6 K) WATER (UNII: 0 59 QF0 KO0 R) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:0 310 -1222- 15 10 in 1 CARTON 1 NDC:0 310 -1222- 10 5 mL in 1 VIAL, MULTI-DOSE; Type 0 : No t a Co mbinatio n Pro duc t MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRA Olvassa el a teljes dokumentumot